Gut microbiota has been recently established to have a contributory role in the development of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing interest has focused on the modulation of gut microbiota as a therapeutic strategy in cardiovascular diseases and metabolic disorders. In this paper, we have reviewed the impact of gut microbiota on metabolic disorders and cardiovascular disease risk, focusing on the newest findings in this field.
Lingua originaleEnglish
pagine (da-a)120-120
Numero di pagine1
RivistaCurrent Cardiology Reports
Stato di pubblicazionePubblicato - 2015


  • Cardiovascular disease
  • Gut microbiota
  • Obesity
  • Platelets
  • Type 2 diabetes


Entra nei temi di ricerca di 'Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk'. Insieme formano una fingerprint unica.

Cita questo